Ticker Scorecard - GERN Basics Company: Geron Corporation IPO Date: July 31, 1996 Sector: Healthcare Industry: Biotech Market Cap: $2.02B Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 2.87% Avg Daily Range (30 D): $0.08 | 2.15% Avg Daily Range (90 D): $0.09 | 2.12% Institutional Daily Volume Avg Daily Volume: 2.55M Avg Daily Volume (30 D): 9.36M Avg Daily Volume (90 D): 8.01M Trade Size Avg Trade Size (Sh.): 333 Avg Trade Size (Sh.) (30 D): 421 Avg Trade Size (Sh.) (90 D): 343 Institutional Trades Total Inst.Trades: 2,281 Avg Inst. Trade: $1.94M Avg Inst. Trade (30 D): $4M Avg Inst. Trade (90 D): $2.56M Avg Inst. Trade Volume: .58M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.46M Avg Closing Trade (30 D): $4.28M Avg Closing Trade (90 D): $4.14M Avg Closing Volume: 793.04K     News Jul 24, 2024 @ 12:17 PM Tesla Posts Weak Earnings, Joins Visa, Deutsche Ba... Source: Avi Kapoor Jun 10, 2024 @ 3:58 PM Geron (GERN) Wins FDA Approval for Blood Cancer Dr... Source: Zacks Equity Research Jun 10, 2024 @ 1:00 PM Critical Insights From Geron Analyst Ratings: What... Source: Benzinga Insights Jun 8, 2024 @ 10:37 AM Is Geron Stock a Buy Following Its First New Drug ... Source: newsfeedback@fool.com (Cory Renauer) Jun 7, 2024 @ 3:30 PM Why Is Exact Sciences (EXAS) Down 17.5% Since Last... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.32 $-.04 $-.1 Diluted EPS $-.32 $-.04 $-.1 Revenue $ 29.48M $ 28.27M $ .88M Gross Profit $ $ $ Net Income / Loss $ -201.19M $ -26.45M $ -67.38M Operating Income / Loss $ -207.97M $ -28.22M $ -69.33M Cost of Revenue $ $ $ Net Cash Flow $ 30.95M $ -55.92M $ -72.79M PE Ratio